Lilly hungry enough for less-mega deals

Eli Lilly chief John Lechleiter may not be up for a mega-merger, but he is looking for acquisitions of as much as $15 billion now that Lilly has digested ImClone Systems. "I got hungry again about three weeks after ImClone got closed" in late November, Dr. Lechleiter told the Wall Street Journal. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.